1-4 of 4
Markus A. Schaich, MD
Close
Sort by
Journal Articles

Early Treatment Intensification in High Risk (HR)-AML Patients Using Allogeneic Hematopoietic Stem Cell Transplantion in a Randomized Multicenter Setting.

Thomas Illmer, MD, Markus A. Schaich, MD, Christian Thiede, MD, Uwe Platzbecker, MD, Wandt Hannes, MD, Ho D. Anthony, MD, Thiel Eckhard, MD, Schmitz Norbert, MD, Einsele Hermann, MD, Neubauer Andreas, MD, Andresen Reinhard, MD, Aulitzky Walter, MD, Haehnel Matthias, MD, Serve Hubert, MD, Berdel Wolfgang, MD, Bornhaeuser Martin, MD, Ehninger Gerhard, MD
Journal: Blood
Blood (2007) 110 (11): 3018.
https://doi.org/10.1182/blood.V110.11.3018.3018
Published: 2007
Journal Articles

MiRNA Expression Signatures in Acute Myeloid Leukemia Are Predictors for Patient Outcome.

Thomas Illmer, MD, David Kosel, Markus A. Schaich, MD, Christian Thiede, MD, Andreas Neubauer, MD, Carsten Mueller-Tidow, MD, Martin Bornhaeuser, MD, Alex Kiani, MD, Gerhard Ehninger, MD, David Brown, PhD, Dimitriy Ovcharenko, PhD
Journal: Blood
Blood (2006) 108 (11): 152.
https://doi.org/10.1182/blood.V108.11.152.152
Published: 2006
Journal Articles

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Frank P. Kroschinsky, MD, Eberhard Schleyer, MD, Kristina Hoelig, MD, Uta Oelschlaegel, PhD, Rainer Ordemann, MD, Kirsten Poppe-Thiede, MD, Markus A. Schaich, MD, Claudia Rutt, MD, Gerhard Ehninger, MD
Journal: Blood
Blood (2005) 106 (11): 5321.
https://doi.org/10.1182/blood.V106.11.5321.5321
Published: 2005
Journal Articles

Early Allogeneic Hematopoietic Cell Transplantation during Induction Chemotherapy in High-Risk Acute Myeloid Leukemia.

Gerhard Ehninger, MD, Uwe Platzbecker, MD, Christian Thiede, MD, Thomas Illmer, MD, Ulrich S. Schuler, MD, Markus A. Schaich, MD, Martin Bornhaeuser, MD
Journal: Blood
Blood (2004) 104 (11): 2299.
https://doi.org/10.1182/blood.V104.11.2299.2299
Published: 2004